Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure

Tianlin He (1, 2) , Jesus Melgarejo (3) , Andrew Clark (4) , Yu‐ling Yu (3) , Lutgarde Thijs (3) , Javier Díez (5, 6, 7) , Begoña López (5, 6, 7) , Arantxa González (5, 6, 7) , John Cleland (8) , Joost Schanstra (9) , Antonia Vlahou (10) , Agnieszka Latosinska (1) , Harald Mischak (1, 8) , Jan Staessen (3) , Zhen‐yu Zhang (3) , Vera Jankowski (2)

1 Mosaiques Diagnostics GmbH [Hanovre, Allemagne]
2 RWTH - Rheinisch-Westfälische Technische Hochschule Aachen University
3 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
4 University of Hull [United Kingdom]
5 Clínica Universidad de Navarra [Pamplona]
6 Institute of Health Carlos III
7 University Clinic of Navarra - CUN [Pamplona, Spain]
8 University of Glasgow
9 I2MC - Institut des Maladies Métaboliques et Cardiovasculaires
10 BRFAA - Biomedical Research Foundation of the Academy of Athens

No abstract available

Domaines: Sciences du Vivant [q-bio]

Tianlin He, Jesus Melgarejo, Andrew Clark, Yu‐ling Yu, Lutgarde Thijs, et al.. Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure. Clinical and Translational Medicine, 2021, 11 (1), pp.1-11. ⟨10.1002/ctm2.267⟩. ⟨hal-03268305⟩